Synergistic Effect of Deinoxanthin-Gambogic acid Combinations on Antiproliferative and Antioxidant Activity in MDA-MB-453 Human Breast Cancer Cells


Creative Commons License

Kılınç S., Toksoy Öner E., Kuzucu M.

7th Drug Chemistry Conference: Design, Synthesis, Production and Standardization of Drug Active Substances, Antalya, Türkiye, 14 - 17 Mart 2019, ss.101

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Antalya
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.101
  • Erzincan Binali Yıldırım Üniversitesi Adresli: Evet

Özet

Deinoxanthin, a unique carotenoid synthesized by the extremophilic bacterium Deinococcus

radiodurans gives the bacterium its characteristic red color1. Deinoxanthin is one of the most important

factor for D. radiodurans resistance to UV radiation, gamma-radiation, desiccation and reactive oxygen

radicals1-2. Morever, deinoxanthin has a pro-apoptotic effect under certain conditions that is it leads

to oxidative stress by either producing ROS or inhibiting antioxidant systems in organism. Choi et al.

showed that Deinoxantin induced apoptosis in prostate and colon cancer2.

Gambogic acid is a Chinese traditional medicine that is derived from Garcinia hanburyi. Because it

inhibits cell proliferation, angiogenesis and metastasis, Gambogic acid has the potential to become an

anti-cancer drug candidate3.

In this research, we investigated the synergistic effect of Deinoxanthin (DX) and gambogic acid (GA) on

breast cancer MDA-MB-453 cells. The synergy was evaluated for total antioxidant and antiproliferative

activities. We determined the levels of total antioxidant capacity and the activity of the antioxidant

enzymes glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase in the DX

and GA-applied cells. Antiproliferative effect was determined by XTT test.